Use of Carnitine to Children with Carditis on the Background of Community - Acquired Pneumonia

Authors

  • Kardjavova Gulnoza Abilkasimovna PhD.. Assistant of the department of 1-Pediatrics and neonatology, Samarkand State Medical University Samarkand, Uzbekistan

Keywords:

carnitine, myocarditis, community-acquired pneumonia, children

Abstract

Pneumonia in children is one of the urgent problems in pediatrics, which is determined by the continuing high incidence and severe prognosis, especially in young children. The aim of the study was to evaluate the effectiveness of the use of carnitine in the treatment and prevention of myocarditis in children with community – acquired pneumonia. We examined 80 children aged 1 to 7 years with pneumonia, which we divided into 2 groups. Group I (control) included 40 children who were on standard treatment. Group II (main) included 40 sick children with pneumonia, who had a violation of the cardiovascular system and parenterally received the drug carnitine. The results obtained underline that the use of carnitine for pneumonia in children reduces the risk of severe unwanted heart complications and reduces the length of hospital stay by an average of 1.8 bed-days in comparison with standard therapy.

References

Basargina E.N. Myocarditis in children: a manual for doctors / E.N. Basargina. - M., 2008. - 27 p.

Clinical and etiological characteristics of community-acquired pneumonia in children and analysis of the effectiveness of antimicrobial therapy / Tsarkova S.A., Beikin Ya.B., Shilova V.P. et al. // Issues of modern pediatrics.-2002.-Vol.1, No.6.-P.32-36.

Clinical guidelines for pediatric cardiology and rheumatology / edited by M.A. Shkolnikova, E.I. Alekseeva. - M., 2011. - 143 p.

Kardjavova G.A., Mukhammadiev I.S. Acute myocarditis in children in the background of community-acquired pneumonia: clinical features Multidisciplinary Scientific Journal Scholar ISSN: 2181-4147 Volume 2 | Issue 3 | January, 2024 p.15-21.

Kardjavova G.A., Rakhmonov R.N., Zubaydullayev S.V. Acute myocarditis in childre on the background of broncho-pulmonary diseases Multidisciplinary Scientific Journal January, 2024 Golden brain ISSN: 2181-4120 volume 2 | issue 3 | 2024 p.70-75.

Karjavova G.A., Rakhmonov R.N., Acute myocarditis in children against the background of community-acquired pneumonia: features of the clinical picture Scientific journal ERUS ISSN: 2181-3515 Volume 3 | Special Issue 3 | January 2024. P-395-400.

Karzhavova G.A. Rakhmonov R.N. New approaches for the etiological aspects of community-acquired pneumonia in children Scientific journal ERUS ISSN: 2181-3515 Volume 3 | Special Issue 3 | January 2024. P-389-394.

Streljaeva, A.V. Toxic cardiopathy and myocarditis of paecilomycosis and other etiology in children / A.V. Streljaeva, H.N. Shadyeva, N.B. Lazareva [et al.] // Russian journal of cardiology. - 2010. - No. 3. - P.46-52.

Published

2024-08-20

How to Cite

Abilkasimovna, K. G. (2024). Use of Carnitine to Children with Carditis on the Background of Community - Acquired Pneumonia. International Journal of Pediatrics and Genetics, 2(8), 15–17. Retrieved from https://medicaljournals.eu/index.php/IJPG/article/view/856